Supriya Ghosh (Editor)

Council of the European Union decisions on designer drugs

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit

Council of the European Union decisions on designer drugs. Council of the European Union issued a set of decisions on 7 designer drugs to make them subject to control measures and criminal provisions.

Contents

List of substances

  • paramethoxymethamphetamine (PMMA)
  • 2C-I
  • 2C-T-2
  • 2C-T-7
  • 2,4,5-trimethoxyamphetamine (TMA-2)
  • benzylpiperazine (BZP)
  • mephedrone (4-MMC)

    • Decisions

    Decisions based on Joint Action 97/396/JHA of 16 June 1997 adopted by the Council on the basis of Article K.3 of the Treaty on European Union, concerning the information exchange, risk assessment and the control of new synthetic drugs:

  • Council Decision 2002/188/JHA of 28 February 2002 concerning control measures and criminal sanctions in respect of the new synthetic drug PMMA
  • Council Decision 2003/847/JHA of 27 November 2003 concerning control measures and criminal sanctions in respect of the new synthetic drugs 2C-I, 2C-T-2, 2C-T-7 and TMA-2

    • Decisions based on Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances:

  • Council Decision 2008/206/JHA of 3 March 2008 on defining 1-benzylpiperazine (BZP) as a new psychoactive substance which is to be made subject to control measures and criminal provisions
  • Council Decision 2010/759/EU of 2 December 2010 on submitting 4-methylmethcathinone (mephedrone) to control measures

    • References

    Council of the European Union decisions on designer drugs Wikipedia
    (Text) CC BY-SA